Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 vs 3 Doses of Hepatitis B Vaccines in Children
NCT04294433Phase 4Completed
- Sponsor
- Université Laval
- Start
- Jun 2018
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pertussis filamentous haemagglutinin and hepatitis A + hepatitis B vaccine in hepatitis B (HBV), sponsored by Université Laval. Started Jun 2018; status: completed.
02
Drugs
pertussis filamentous haemagglutininhepatitis A + hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04294433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294433.